Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivatives
申请人:Cell Pathways, Inc.
公开号:US06211177B1
公开(公告)日:2001-04-03
A method for inhibiting neoplasia, particularly cancerous and precancerous lesions, by exposing the affected cells to substituted 2-aryl-benzimidazoles.
一种通过将受影响的细胞暴露于取代的2-芳基苯并咪唑类化合物来抑制肿瘤,特别是癌症和癌前病变的方法。